US 7482351
4-pyrimidineamine compounds and their uses as anti-proliferative agents
granted A61PA61P35/00A61P35/04
Quick answer
US patent 7482351 (4-pyrimidineamine compounds and their uses as anti-proliferative agents) held by Rigel Pharmaceuticals, Inc. expires Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 27 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 22 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00, A61P35/04